Increased Co-Expression of PD-L1 and CTLA-4 Predicts Poor Overall Survival in Patients with Acute Myeloid Leukemia ...
Introduction Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the most effective consolidation therapy for patients with intermediate and high-risk acute myeloid leukemia (AML).1 Although allo-HSCT significantly improves the long-term …